Marilena Vrana on Expanding Plasma Donations in Europe
David McIntosh, Founder and Chair of United Plasma Action, shared a post by PPTA Europe on LinkedIn:
”This post is a beacon of hope for all EU Member States – and other countries throughout the World.
Wherever Voluntary Un-Compensated Donation (VUCD) is failing to deliver what patients need (which is EVERYWHERE!), the well tested and thoroughly proven system of VRCD (Voluntary Reasonably Compensated Donation) stands ready to do the job properly.
All that’s needed is national willpower and determination to make a real difference – on behalf of patients in need.”
Quoting PPTA Europe‘s post:
“In this video, Marilena Vrana, Vice President of Public Affairs and EU Operations, shares why Europe must boost plasma collection, points to countries setting strong examples, and explains how plasmapheresis is key to making it happen.
Many rare disease patients lack reliable access to plasma-derived medicines across Europe and worldwide.
Access to these life-saving therapies starts with collecting sufficient plasma for fractionation; and meeting the growing clinical need requires stronger collaboration from all stakeholders.
Share this video and help spread the word.”
See the PPTA Europe post here.

Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator